...
首页> 外文期刊>Polymer bulletin >Crosslinking of poly(N-vinyl pyrrolidone-co-n-butyl methacrylate) copolymers for controlled drug delivery
【24h】

Crosslinking of poly(N-vinyl pyrrolidone-co-n-butyl methacrylate) copolymers for controlled drug delivery

机译:聚(N-乙烯基吡咯烷酮-甲基丙烯酸正丁酯)共聚物的交联以控制药物输送

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Poly(N-vinyl pyrrolidone-co-n-butyl methacrylate) P(NVP-co-nBMA) copolymers containing high N-vinyl pyrrolidone content were crosslinked to increase their hydro-stable nature for controlled drug delivery. Diethylene glycol dimethac-rylate (DEGDMA) and trimethylolpropane trimethacrylate (TMPTMA) were used as crosslinkers. The effect of crosslinker concentration and functionality on gel content, thermal stability and water uptake at 37 °C was investigated. The gel contents and thermal stability increased while water uptake decreased with increasing concentration and functionality of crosslinker. The copolymer crosslinked by TMPTMA showed good mechanical properties. The porous network structure of the copolymers was confirmed by scanning electron microscopic studies. Dexamethasone was selected as a model drug and its controlled release was observed for 22 days from TMPTMA crosslinked copolymer (NB91-T2) film, whereas 96 % drug was released in 35 days for DEGDMA crosslinked copolymer (NB91-D2) film. The kinetics of 10 h drug release identified first-order drug release for NB91-D2 and Higuchi kinetics for NB91-T2. The initial 60 % drug release followed non-Fickian diffusion mechanism. These results indicate the future application of NB91-D2 and NB91-T2 copolymer films as a drug carrier for implant coatings.
机译:含有高N-乙烯基吡咯烷酮含量的聚(N-乙烯基吡咯烷酮-甲基丙烯酸正丁酯)P(NVP-co-nBMA)共聚物被交联以增加其水稳性,以控制药物的输送。二乙二醇二甲基丙烯酸酯(DEGDMA)和三羟甲基丙烷三甲基丙烯酸酯(TMPTMA)被用作交联剂。研究了交联剂浓度和官能度对凝胶含量,热稳定性和37°C吸水率的影响。随着交联剂浓度和功能的增加,凝胶含量和热稳定性提高,而吸水率降低。通过TMPTMA交联的共聚物显示出良好的机械性能。通过扫描电子显微镜研究证实了共聚物的多孔网络结构。选择地塞米松作为模型药物,在TMPTMA交联共聚物(NB91-T2)薄膜中观察到其控释22天,而在DEGDMA交联共聚物(NB91-D2)薄膜中有96%药物释放。药物释放10小时的动力学确定了NB91-D2的一级药物释放和NB91-T2的Higuchi动力学。最初的60%药物释放遵循非菲克扩散机制。这些结果表明,NB91-D2和NB91-T2共聚物薄膜作为植入涂层药物载体的未来应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号